Development Pipeline

Our NaviCap targeted oral delivery platform uses a smart capsule designed for targeted delivery of therapeutics to the large intestine to achieve sufficient tissue concentration. Delivering therapeutics directly to the site of disease could enable safer and more effective treatment of inflammatory bowel disease (IBD).

Our BioJet systemic oral delivery platform uses an ingestible capsule designed for liquid jet delivery of biotherapeutics into the small intestine for systemic uptake. Needle-free delivery could replace injection for better management of chronic diseases.